Clinical Trial Update: Phase II Study Evaluating the Efficacy of Aflibercept for the Treatment of Choroidal Neovascularization in Angioid Streaks in Young Patients (ASTRID). [Phase 2]

View source ↗

Summary

A Phase II study evaluating aflibercept for choroidal neovascularization associated with angioid streaks has been withdrawn. The sponsor listed is Hospices Civi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angioid Streaks
• Choroidal Neovascularization

Drugs mentioned

• Aflibercept (Aflibercept)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Choroidal Neovascularization in Angioid Streaks | Phase 2 | Status: WITHDRAWN